DIRS.INFO The most relevant business & tech news

Short interest in Novavax increased more than 13% to 37.8 million shares, or about 45% of the total float, between March 15-31, according to data compiled by FactSet. Other biotech companies that saw growing short interest are Cassava Sciences , with a 10% increase, and Fate Therapeutics , which saw a 26% boost. Meanwhile, bluebird bio had a 29% increase in its short interest to 26% of float. Cinemark and AMC Entertainment both saw increases in their short position to 28% and 27% of their respective floats. All names trade on the NYSE or Nasdaq, have short positions amounting to at least 25% of their total float and have market values of at least $100 million.

☆ Shares of this under-the-radar cell therapy stock are set to double, says Baird
▼ + stars: | 2023-03-07 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Shares of biotech company bluebird bio should double in the coming year, thanks to its treatments for sickle cell disease, a genetic blood disease and a rare genetic brain condition, according to Baird. The Wall Street firm initiated coverage of the stock on Monday with an outperform rating and $10 price target, which implies 104% upside from Monday's close. The company's management said in January that 40 patients had initiated benefits verification for Zynteglo during the last three months of 2022. Lastly, Baird expects the use of bluebird's Skysona treatment for CALD, which was approved in September 2022, to increase significantly in the coming years. The under-the-radar stock, which has a market cap of over $500 million, is down about 29% this year, as of Monday's close.

☆ Here are Tuesday's biggest analyst calls: Apple, Amazon, Arista, Costco, Joby, Netflix & more
▼ + stars: | 2023-03-07 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Tuesday's biggest calls on Wall Street: Northcoast upgrades Costco to buy from hold Northcoast said it sees more upside for the wholesale retailer. " Goldman Sachs initiates Arista Networks and Juniper as buy Goldman initiated several networking equipment stocks, noting they are attractively valued. Deutsche Bank downgrades Joby to sell from hold Deutsche said it sees too many risks for the aviation company. Morgan Stanley reiterates Walmart as overweight Morgan Stanley said its standing by shares of Walmart as the retail giant continues to sign up new members for its Walmart+. Loop reiterates Netflix as hold Loop said its survey checks show that password sharing charging is increasing revenue for Netflix.

☆ Storms in California have led to high snowpack and great skiing conditions — but the deluge still may not be enough to fill the state's empty reservoirs after years of drought
▼ + stars: | 2023-01-06 | by ( Kelsey Vlamis | ) www.businessinsider.com time to read: +5 min

California has faced heavy precipitation in recent weeks, leading to a high snowpack. The snowpack provides a third of California's water needs, but it's too soon to assess the impact on the drought. The snowpack in the Sierra Nevada, the mountain range that runs along the eastern part of the state, is often called California's "frozen reservoirs." Though the high snowpack this early in the season is promising, if the precipitation doesn't continue, it may not be enough to significantly address the drought. "It's great for the state of California to get out of this drought, and it's great for skiing."

☆ Drug Prices Reach New High—in the Millions
▼ + stars: | 2022-12-26 | by ( Peter Loftus | ) www.wsj.com time to read: 1 min

The most recent gene therapy approved in the U.S. set a price record: $3.5 million for CSL’s Hemgenix, a treatment for hemophilia B. A new era of expensive drugs has arrived: medicines priced in the millions of dollars a patient. Since August, U.S. or European health regulators have approved four new products intended as one-time treatments for rare genetic diseases that carry list prices of at least $2 million a patient, including two from Bluebird Bio Inc.

☆ The most expensive drug in the world has a $3.5 million price tag. 2 potential patients share their hopes and fears for the one-time treatment.
▼ + stars: | 2022-12-05 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +7 min

The FDA has approved a new gene therapy to treat hemophilia B, a genetic bleeding disorder. The drugmaker CSL Behring set a $3.5 million price for the one-time treatment. Lackey is learning to live with a severe case of hemophilia B, a rare genetic condition that keeps blood from clotting properly. But a critical unknown in judging CSL's $3.5 million price is the durability of the treatment. Lojewski said the $3.5 million price wasn't guided by other gene-therapy prices.

☆ The most expensive drug in the world just got approved at $3.5 million, and hemophilia patients are conflicted: 'Compared to what we pay, it doesn't seem too terrible.'
▼ + stars: | 2022-12-01 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +7 min

The FDA has approved a new gene therapy to treat hemophilia B, a genetic bleeding disorder. Hemophilia patients told Insider they're excited about the new drug but worried about the price. Lackey is learning to live with a severe case of hemophilia B, a rare genetic condition that keeps blood from clotting properly. While the treatment breaks ground as the first approved gene therapy for hemophilia, its price is also unprecedented. Lojewski said the $3.5 million price wasn't guided by other gene-therapy prices.

☆ Regulators have approved the world's most expensive medicine that costs $3.5 million per patient
▼ + stars: | 2022-11-24 | by ( Ryan Hogg | ) www.businessinsider.com time to read: +3 min

The FDA approved a treatment costing $3.5 million, making it the world's most expensive medicine. Hemgenix effectively treated several patients with the blood condition Hemophilia B in trials. An independent study said a fair price for the drug would be about $2.9 million. download the app Email address By clicking ‘Sign up’, you agree to receive marketing emails from Insider as well as other partner offers and accept our Terms of Service and Privacy PolicyUS regulators have approved a hemophilia drug that will cost $3.5 million per patient, making it the world's most expensive medicine. However, the drug will have a list price of $3.5 million per dose, Managed Healthcare Executive reported, making it the world's most expensive medicine by some distance.

Nov 22 (Reuters) - Australian drugmaker CSL Ltd (CSL.AX) on Tuesday set the list price of its one-time gene therapy for hemophilia B at $3.5 million, making it the world's most expensive treatment, following its approval by the U.S. health regulator. The first gene therapy for the rare genetic blood clotting disorder offers a long-term solution for patients as against current treatments from Biogen (BIIB.O), Pfizer (PFE.N) and others that focus on regular infusions. The gene therapy consists of an engineered virus carrying a gene expressed in the liver to produce clotting factor IX. While Zynteglo was priced at $2.8 million, Skysona had a wholesale cost of $3.0 million. CSL shares were up 1% at A$300.62 on the Australian stock exchange, while UniQure stock edged up 0.9% in extended trading.

☆ 'I don't want to work with these clowns.' Inside the culture war that Elon Musk has unleashed at Twitter.
▼ + stars: | 2022-11-04 | by ( Mattathias Schwartz | ) www.businessinsider.com time to read: +8 min

With a project, you could see who initiated the work, who was the assignee, who was in the chain of command. They wanted to make Twitter a place to exchange ideas and observations that were funny, factual and engaging. Whenever I'm on Twitter, I always find something that makes me laugh, or learn something. It feels like that's what's happening. What's even more frightening is that I don't see any viable alternatives to Twitter right now.

☆ The anesthesiologist who is putting you under may work for a private-equity firm
▼ + stars: | 2022-10-10 | by ( Gretchen Morgenson | Gretchen Morgenson Is The Senior Financial Reporter For The Nbc News Investigative Unit. A Former Stockbroker | She Won The Pulitzer Prize In For Her | ) www.nbcnews.com time to read: +12 min

But some physicians and patient advocates say the health care investments of private-equity firms and their drive to reap relatively short-term profits are inconsistent with putting patients first. Independent academic studies find that private equity’s laser focus on profits in health care operations can result in lower staffing levels at hospitals and nursing homes. Neither the FTC nor U.S. Anesthesia Partners responded to voice mails seeking comment; a spokesman for U.S. Anesthesia Partners confirmed the inquiry to the Journal, saying it is cooperating. NBC News asked both of NAPA’s private-equity owners about the disputes involving the company and the research showing higher costs associated with private-equity ownership of anesthesiology practices. Covid was sweeping the country and Moses Taylor was doing its best to respond to the health care crisis, according to its lawsuit.

☆ Amex Offers can save you money at merchants like Dell, Under Armour, Hyatt, and Best Western — here are some of the best offers you can get right now
▼ + stars: | 2022-10-10 | by ( Jasmin Baron | Read More | Read Less | ) www.businessinsider.com time to read: +10 min

One of those benefits, available with virtually every American Express card but not the most widely known, is Amex Offers. For example, close to Valentine's Day and Mother's Day, there are often Amex Offers to save on flowers and gifts. Amex Offers for shopping, services, and diningAmex Offers for travelHow to find your Amex Offers Log in to your online Amex account. Amex Offers frequently asked questions (FAQ)Which American Express cards are eligible for Amex Offers? New Amex Offers are added to accounts nearly all the time, but there's no schedule or regular frequency.

☆ Stocks making the biggest moves in the premarket: AutoZone, Take-Two Interactive, bluebird bio and more
▼ + stars: | 2022-09-19 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Take-Two Interactive (TTWO) – Take-Two shares slid 5.8% in the premarket after Bloomberg reported that a hacker released gameplay from its upcoming Grand Theft Auto IV game online. bluebird bio (BLUE) – bluebird bio rallied 7.3% in premarket trading after the Food and Drug Administration approved the company's gene therapy for a rare and lethal brain disease in children. Wix (WIX) – Wix shares jumped 4.5% in premarket action after activist investor Starboard Value revealed a 9% stake in the web development platform company. NCR (NCR) – NCR slid another 1.3% in the premarket on top of a 20.3% plunge Friday after Morgan Stanley downgraded the stock to "equal-weight" from "overweight." Adobe fell 1.3% in premarket trading after falling 16.8% last Thursday and another 3.1% on Friday.

☆ Amex Offers can save you money at merchants like Alaska Airlines, Hotels.com, Boxed, and Spirit Halloween — here are some of the best offers you can get right now
▼ + stars: | 2022-09-12 | by ( Jasmin Baron | Read More | Read Less | ) www.businessinsider.com time to read: +7 min

The latest round of Amex Offers includes bonus points and discounts at popular online stores and on tax services, airlines, hotels, flowers, and gifts. One of the appeals of the Amex Offers program is that the offers continuously change. For example, close to Valentine's Day and Mother's Day, there are often Amex Offers to save on flowers and gifts. Amex Offers for shopping, services, and diningAmex Offers for travelHow to find your Amex Offers Log in to your online Amex account. Amex Offers frequently asked questions (FAQ)Which American Express cards are eligible for Amex Offers?

Search resuls for: "bluebird"

14 mentions found